Belatacept: Is there BENEFIT for liver transplantation too?

S. J. Knechtle, A. B. Adams

Research output: Contribution to journalEditorialpeer-review

11 Scopus citations

Abstract

The results of the multicenter belatacept liver transplant trial disappoint with respect to safety and efficacy, and new approaches will be required before this agent plays a role in liver transplant immunosuppression. See article by Klintmalm et al on page 1817.

Original languageEnglish (US)
Pages (from-to)1717-1718
Number of pages2
JournalAmerican Journal of Transplantation
Volume14
Issue number8
DOIs
StatePublished - Aug 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Belatacept: Is there BENEFIT for liver transplantation too?'. Together they form a unique fingerprint.

Cite this